Related Experiment Videos
Interleukin-13 in systemic sclerosis: relationship to nailfold capillaroscopy abnormalities
V Riccieri1, T Rinaldi, A Spadaro
1Dipartimento di Terapia Medica, Cattedra di Reumatologia, Università di Roma 'La Sapienza', 00185, Rome, Italy.
Clinical Rheumatology
|May 13, 2003
Summary
Interleukin-13 (IL-13) serum levels are elevated in systemic sclerosis (SSc) patients. Higher IL-13 correlates with specific nailfold capillaroscopy (NC) abnormalities, suggesting a role in microvascular damage.
Area of Science:
- Rheumatology
- Immunology
- Dermatology
Background:
- Systemic sclerosis (SSc) is characterized by microvascular abnormalities.
- Nailfold capillaroscopy (NC) is crucial for assessing these vascular changes.
- Interleukin-13 (IL-13) is an inflammatory cytokine implicated in fibrotic diseases.
Purpose of the Study:
- To investigate the correlation between serum IL-13 levels and nailfold capillaroscopy (NC) findings in SSc patients.
- To determine if IL-13 is associated with specific microvascular lesions observed in SSc.
Main Methods:
- Serum IL-13 levels were quantified using ELISA.
- Nailfold capillaroscopy (NC) abnormalities were assessed, including giant loops, hemorrhages, capillary loss, and vascular disorganization.
- Morphological NC patterns ('early', 'active', 'late'), avascular areas, capillary density, and diameters were evaluated.
Main Results:
- SSc patients exhibited significantly higher serum IL-13 levels compared to controls.
- Elevated IL-13 serum levels (>17 pg/ml) were associated with a more frequent 'active' NC pattern.
- Higher IL-13 correlated with increased presence of hemorrhages, blood sludging, and larger arterial/total loop diameters.
Conclusions:
- Serum IL-13 levels are elevated in SSc patients.
- This study demonstrates a significant correlation between elevated IL-13 and key SSc capillaroscopic features.
- IL-13 may contribute to the immunological and fibrotic processes, and potentially severe microvascular lesions in SSc.